Tenofoshiv EM tablets are a combination antiretroviral therapy (ART) used for treating HIV-1 infection and for PrEP (pre-exposure prophylaxis). Key components include 300 mg Tenofovir Disoproxil Fumarate (TDF) and 200 mg Emtricitabine. It is primarily marketed for HIV treatment, managing viral load, and preventing transmission.